National Cancer Institute; Amended Notice of Meeting, 68678 [2021-26273]

Download as PDF 68678 Federal Register / Vol. 86, No. 230 / Friday, December 3, 2021 / Notices Authority: 42 U.S.C. 200u. Paul Reed, Deputy Assistant Secretary for Health,RADM, U.S. Public Health Service, Office of Disease Prevention and Health Promotion. [FR Doc. 2021–26184 Filed 12–2–21; 8:45 am] BILLING CODE 4150–32–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting jspears on DSK121TN23PROD with NOTICES1 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; HostBacterial Interactions and Infections. Date: December 14, 2021. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Pauline Cupit, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 827–3275, cupitcunninghpm@ mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 29, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–26247 Filed 12–2–21; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 18:06 Dec 02, 2021 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Cancer Advisory Board and NCI Board of Scientific Advisors, December 7, 2021, 1:00 p.m. to December 9, 2021, 5:00 p.m., National Cancer Institute-Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 which was published in the Federal Register on October 05, 2021, FR Doc 2021–21666, 86 FR 54990. This notice is being amended to change the open session end time and agenda on December 7, 2021. There will now only be one NCAB Subcommittee Meeting held on December 7, 2021, the Ad Hoc Subcommittee on Experimental Therapeutics from 1:15 p.m. to 2:15 p.m. This notice is also being amended to change the open session end times on December 8, 2021 and December 9, 2021. The open session end time on December 8, 2021 has changed from 5:00 p.m. to 5:30 p.m., as such, the meeting will now be held from 1:00 p.m. to 5:30 p.m. The open session end time on December 9, 2021 has changed from 5:00 p.m. to 5:15 p.m., as such, the meeting will now be held from 1:00 p.m. to 5:15 p.m. The meeting is partially closed to the public. Dated: November 30, 2021. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–26273 Filed 12–2–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Cell, Molecular Biology and Special Topics. Date: December 15, 2021. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Ronit I. Yarden, Ph.D., MHSA, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 904B, Bethesda, MD 20892, (202) 552–9939, yardenri@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: November 29, 2021. David W. Freeman, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–26250 Filed 12–2–21; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; AI/ML strategies to integrate genetics and multiomics data from human cohort studies to improve quality of life of Older Adults with MCI and ADRD. Date: January 19, 2022. Time: 1:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\03DEN1.SGM 03DEN1

Agencies

[Federal Register Volume 86, Number 230 (Friday, December 3, 2021)]
[Notices]
[Page 68678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26273]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Cancer Advisory Board and NCI Board of Scientific Advisors, December 7, 
2021, 1:00 p.m. to December 9, 2021, 5:00 p.m., National Cancer 
Institute-Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 
which was published in the Federal Register on October 05, 2021, FR Doc 
2021-21666, 86 FR 54990.
    This notice is being amended to change the open session end time 
and agenda on December 7, 2021. There will now only be one NCAB 
Subcommittee Meeting held on December 7, 2021, the Ad Hoc Subcommittee 
on Experimental Therapeutics from 1:15 p.m. to 2:15 p.m.
    This notice is also being amended to change the open session end 
times on December 8, 2021 and December 9, 2021. The open session end 
time on December 8, 2021 has changed from 5:00 p.m. to 5:30 p.m., as 
such, the meeting will now be held from 1:00 p.m. to 5:30 p.m. The open 
session end time on December 9, 2021 has changed from 5:00 p.m. to 5:15 
p.m., as such, the meeting will now be held from 1:00 p.m. to 5:15 p.m. 
The meeting is partially closed to the public.

    Dated: November 30, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-26273 Filed 12-2-21; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.